Form 4 for SNTI Senti Biosciences Holdings, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001628280-26-016795 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-09 | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | F - Tax | $0.00 | -10.8K | 74.8K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | F | D | 10,757 | $0.00 | 74,843 | D | — | — | (F1) Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale. |